Clinical Trial Update: Nitrocamptothecin in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of nitrocamptothecin in patients with metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED